NewslettersDermal Cell News Inhibiting SCD Expression by IGF1R during Lorlatinib Therapy Sensitizes Melanoma to Ferroptosis By Laurisa Dohm - March 13, 2023 0 The authors used a drug synergy screen that combined a ferroptosis inducer, RSL3, with 240 anti-tumor drugs from the FDA-approved drug library and identified lorlatinib to synergize with RSL3 in melanoma cells. [Redox Biology] Full Article